Evolocumab, added to statins may help lower cholesterol

Evolocumab, added to statins may help lower cholesterol

Evolocumab, added to statins may help lower cholesterol

"The prices that are actually being paid by payers in the USA marketplace today, after the rather large rebating that goes on, are right in the middle of the value range for a product like this".

Still, Elliott Levy, Amgen's senior vice president of global development, said the study results were "about as good a result as you can get".

Amgen, though, claims that Repatha is worth the price and its value has been proven conclusively with the study.

"These results, I think, will mean the guidelines are adjusted slightly, but unless the price comes down it won't mean we give it to anyone by any means", said Professor Naveed Sattar, a metabolic medicine expert of the University of Glasgow, according to The Daily Mail. The shares were down on the data, as the risk reduction on the primary endpoint (15%) was at the low end of expectations, despite still being significant. The top line here is that for this population, it is going to be hard to justify the cost of these [PCSK9] medicines for the magnitude of the risk reduction, Weiss added. Insurance companies have been trying to escape costly Repatha and have asked the company to provide better proof of reduction in heart disease risk.

The patients in the trial were already taking statins, which are used to reduce low-density lipoprotein (LDL) cholesterol.

The ORION-1 trial presented at ACC looked at the effects on LDL-c of one or two injections of inclisiran at three doses (200 mg, 300 mg and 500 mg) compared to placebo over more than six months, and updated previous results reported past year. The FDA approved Repatha and Regeneron Pharma's (REGN) Praluent on that basis.

Amgen's cholesterol drug Repatha (evolocumab) has showed positive effect in a 27,564-patient cardiovascular outcomes study. The researchers randomized patients to receive either injections of Repatha or placebo, and followed them for 2 years to track several cardiovascular events: heart attack, stroke, death, hospitalization for blocked blood flow to the heart, and stent or bypass surgery.

Neurocognitive adverse events, in the full cohort, were reported for 19 (1.9%) in the evolocumab group, compared to 16 (1.6%) in the placebo group. The difference equates to a 1.5 percentage point absolute reduction in cardiovascular outcome risk and a 15% relative reduction favoring Repatha.

As a result, manufacturers decided to make a clinical trial, and they presented the results at the American College of Cardiology meeting held last Friday.

A New Florida Prosecutor Says 'No' to the Death Penalty
Then, while on the run after killing the officer, Loyd killed an Orange County sheriff's deputy in a auto accident. Rick Scott transferred the case from her authority to another State Attorney in a neighboring district.

The PCSK9 protein helps to control the amount of bad cholesterol in the blood by regulating the number of LDL receptor proteins on cell surfaces, which take LDL out of circulation.

Nearly 14,000 patients were recruited to the treatment arm of the study, receiving the drug over a 48-week period.

According to a statement published in The New England Journal of Medicine, the study included 27,564 patients between 40 and 85 years old with atherosclerotic cardiovascular disease and LDL cholesterol levels of 70 mg per deciliter or higher.

The investigators who conducted the FOURIER study noted Repatha's benefit grows over time.

"It's remarkable to see such a large impact in reducing cardiac events given that this patient population was only on Repatha for about two years".

Aiming to address questions about its cognitive effects, researchers at Brigham and Women's Hospital in collaboration with Brown University and the University of Geneva ran cognitive tests on almost 2,000 people enrolled in a two-year study of the drug.

Amgen believes the numbers are strong enough to change clinical practice, though.

"However, the trial was stopped early after only 2.2 years of average follow-up", Sir Nilesh said.

Recommended News

  • Durant cleared to travel with Warriors

    Durant cleared to travel with Warriors

    That leaves Westbrook seven triple-doubles shy of Oscar Robertson's record of 41 in a single season from the 1961-62 campaign. Sacramento won its past two contests after suffering through an eight-game losing streak.

    Midwest Region Free Pick: Oklahoma St. vs. MI

    The star guard missed a critical front end of a 1-and-1, and Walton made it hurt with a conversion in the lane for an 86-79 lead. This is the third time this season MSU and Kansas have been at the same neutral site and the first time they've met.
    The

    The "Catournament" Journal: A initiation into March Madness

    The Commodores were very much still in the game after Fisher-Davis' foul, and it was not the biggest turning point in the match. However, Vanderbilt likely wouldn't have been in a position to make an error like that if it weren't for Fisher-Davis.
  • Former teacher may have planned alleged abduction of teen, police say

    Former teacher may have planned alleged abduction of teen, police say

    No matter how far you've gone or what is happening right now, God's grace is sufficient for you and he wants you to come home". According to reports, authorities believe Elizabeth Thomas was in Decatur, Alabama, on the afternoon of her disappearance.
    Yogi Adityanath Sworn In as Uttar Pradesh Chief Minister

    Yogi Adityanath Sworn In as Uttar Pradesh Chief Minister

    On portfolios, Sharma said that no decision has been taken in this regard as of now and the chief minister will decide it later. He is known for inciting communal hatred and a preacher of the dangers of love-jihad and has been an advocate of ghar wapsi.

    Israeli fighter jets escape missiles from pro-Assad forces during Syria mission

    Hezbollah and Israel fought a 34-day war along the Israel-Lebanon border in 2006 and both sides say they are prepared for another. An Israeli army statement said "several anti-aircraft missiles" were fired following the raid but that none hit their targets.
  • Andy Murray Withdraws from Miami Open with Elbow Injury

    Andy Murray Withdraws from Miami Open with Elbow Injury

    The tournament has already received a significant blow with world number one Andy Murray sitting out due to his own elbow injury. Reports claimed that the former world number one went back to Monaco to consult doctor.
    Pavel Nedved: 'Juventus are capable of challenging Barcelona'

    Pavel Nedved: 'Juventus are capable of challenging Barcelona'

    Juventus will try to take their revenge for the 2015 Champions League final which they lost against the blaugrana for 3-1. The La Liga champions beat Juve 3-1 in the final played at the Berlin Olympic stadium.
    Suspect involved in EMT murder arrested

    Suspect involved in EMT murder arrested

    A passing Metropolitan Transportation Authority K-9 officer subdued the 25-year-old suspect with the help of a bystander. A New York Fire Department (FDNY) paramedic has died after she was run over by a man driving her stolen ambulance.
  • Rinehart soars up Forbes Rich List but Trump tumbles

    Rinehart soars up Forbes Rich List but Trump tumbles

    Microsoft founder and philanthropist Bill Gates topped the list for the fourth time in a row with a net worth of $112 billion. The total combined net worth of this year's billionaires was $7.67 trillion, up from $6.48 trillion last year.
    Missing Muslim clerics to return to India on March 20

    Missing Muslim clerics to return to India on March 20

    Nizami also informed that the phone of the clerics was now ringing, adding that they would be able to talk to them very soon. The two had reached the Pakistani port city to meet their relatives after visiting the Data Darbar Sufi shrine in Lahore.

    Kyrgios to face Federer in Indian Wells

    Should Kyrgios defeat Federer as well, it could give us some big answers, thinks former doubles number one Todd Woodbridge. The rivalry between 14-time Grand Slam and the 18-time winners is one of the most exciting in the history of tennis.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.